Strides Pharma hits all time high after USFDA approval for this drug | News on Markets
Strides Pharma share price hit an all-time high after its Singapore subsidiary received USFDA approval for generic Theophylline extended-release tablets, to be manufactured in Bangalore.
Reference News
Strides Pharma hits all time high after USFDA approval for this drug | News on Markets
Strides Pharma share price hit an all-time high after its Singapore subsidiary received USFDA approval for generic Theophylline extended-release tablets, to be manufactured in Bangalore.
Strides Pharma Share Price Jumps after Theophylline Tablet Gets US FDA Approval
Strides Pharma shares surged to an all-time high of ₹1,395 after its subsidiary received USFDA approval for a generic Theophylline extended-release tablet, enhancing its U.S. market presence.